Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy

Objective: To assess the prevalence of somatic MTOR mutations in focal cortical dysplasia (FCD) and of germline MTOR mutations in a broad range of epilepsies. Methods: We collected 20 blood-brain paired samples from patients with FCD and searched for somatic variants using deep-targeted gene panel sequencing. Germline mutations in MTOR were assessed in a French research cohort of 93 probands with focal epilepsies and in a diagnostic Danish cohort of 245 patients with a broad range of epilepsies. Data sharing among collaborators allowed us to ascertain additional germline variants in MTOR. Results: We detected recurrent somatic variants (p.Ser2215Phe, p.Ser2215Tyr, and p.Leu1460Pro) in the MTOR gene in 37% of participants with FCD II and showed histologic evidence for activation of the mTORC1 signaling cascade in brain tissue. We further identified 5 novel de novo germline missense MTOR variants in 6 individuals with a variable phenotype from focal, and less frequently generalized, epilepsies without brain malformations, to macrocephaly, with or without moderate intellectual disability. In addition, an inherited variant was found in a mother–daughter pair with nonlesional autosomal dominant nocturnal frontal lobe epilepsy. Conclusions: Our data illustrate the increasingly important role of somatic mutations of the MTOR gene in FCD and germline mutations in the pathogenesis of focal epilepsy syndromes with and without brain malformation or macrocephaly.

[1]  Sara Chandros Hull,et al.  Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011)) , 2016 .

[2]  Beth K. Martin,et al.  Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. , 2016, JAMA neurology.

[3]  Yubin Xie,et al.  GPS-Lipid: a robust tool for the prediction of multiple lipid modification sites , 2016, Scientific Reports.

[4]  Nikhil Wagle,et al.  Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. , 2016, American journal of human genetics.

[5]  M. Baulac,et al.  Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia , 2016, Epilepsia.

[6]  I. Blümcke,et al.  Somatic mutations rather than viral infection classify focal cortical dysplasia type II as mTORopathy. , 2016, Current opinion in neurology.

[7]  I. Sobhani,et al.  A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker. , 2016, Clinical chemistry.

[8]  Elisa de Stanchina,et al.  Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor , 2016, Nature.

[9]  O. Steinlein,et al.  Nocturnal frontal lobe epilepsy caused by a mutation in the GATOR1 complex gene NPRL3 , 2016, Epilepsia.

[10]  I. Scheffer,et al.  Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy , 2015, Annals of neurology.

[11]  P. Lockhart,et al.  Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3 , 2015, Annals of neurology.

[12]  S. Baulac.  mTOR signaling pathway genes in focal epilepsies. , 2016, Progress in brain research.

[13]  E. McPherson,et al.  Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities , 2015, BMC Medical Genetics.

[14]  Y. Ishikawa,et al.  Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer , 2015, Cancer science.

[15]  Peter J. Park,et al.  Somatic mutation in single human neurons tracks developmental and transcriptional history , 2015, Science.

[16]  P. Striano,et al.  DEPDC5 mutations are not a frequent cause of familial temporal lobe epilepsy , 2015, Epilepsia.

[17]  H. Kitaura,et al.  Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb , 2015, Annals of neurology.

[18]  Ayal B. Gussow,et al.  The Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity , 2015, PLoS genetics.

[19]  Gareth Baynam,et al.  A germline MTOR mutation in Aboriginal Australian siblings with intellectual disability, dysmorphism, macrocephaly, and small thoraces , 2015, American journal of medical genetics. Part A.

[20]  P. Lockhart,et al.  Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR , 2015, Neurology.

[21]  Seok-Gu Kang,et al.  Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy , 2015, Nature Medicine.

[22]  A. Biraben,et al.  Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations , 2015, Annals of neurology.

[23]  Beth K. Martin,et al.  Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia , 2015, Annals of neurology.

[24]  P. Lockhart,et al.  Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5 , 2015, Annals of clinical and translational neurology.

[25]  M. Baulac,et al.  DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy , 2014, Neurology.

[26]  Qi Zhao,et al.  GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs , 2014, Nucleic Acids Res..

[27]  I. Scheffer,et al.  Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations , 2014, Annals of neurology.

[28]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[29]  E. Aronica,et al.  Epilepsy Related to Developmental Tumors and Malformations of Cortical Development , 2014, Neurotherapeutics.

[30]  Laurie D. Smith,et al.  Exome Sequencing Reveals De Novo Germline Mutation of the Mammalian Target of Rapamycin (MTOR) in a Patient with Megalencephaly and Intractable Seizures , 2013 .

[31]  R. Miles,et al.  Mutations of DEPDC5 cause autosomal dominant focal epilepsies , 2013, Nature Genetics.

[32]  François Dubeau,et al.  Mutations in DEPDC5 cause familial focal epilepsy with variable foci , 2013, Nature Genetics.

[33]  N. Pavletich,et al.  mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain , 2013, Nature.

[34]  Matthew Meyerson,et al.  A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1 , 2013, Science.

[35]  De novo mutations in epileptic encephalopathies , 2013 .

[36]  Richard J. Edwards,et al.  ELM—the database of eukaryotic linear motifs , 2011, Nucleic Acids Res..

[37]  Zexian Liu,et al.  GPS-YNO2: computational prediction of tyrosine nitration sites in proteins. , 2011, Molecular bioSystems.

[38]  Maria Thom,et al.  The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission 1 , 2011, Epilepsia.

[39]  Zexian Liu,et al.  GPS-SNO: Computational Prediction of Protein S-Nitrosylation Sites with a Modified GPS Algorithm , 2010, PloS one.

[40]  D. Sabatini,et al.  DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.

[41]  Keehyoung Joo,et al.  Improving physical realism, stereochemistry, and side‐chain accuracy in homology modeling: Four approaches that performed well in CASP8 , 2009, Proteins.

[42]  Changjiang Jin,et al.  CSS-Palm 2.0: an updated software for palmitoylation sites prediction. , 2008, Protein engineering, design & selection : PEDS.

[43]  N. Blom,et al.  Prediction of post‐translational glycosylation and phosphorylation of proteins from the amino acid sequence , 2004, Proteomics.

[44]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[45]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.